Literature DB >> 26113437

Newborn screening blood spot analysis in the UK: influence of spot size, punch location and haematocrit.

A J Lawson1, L Bernstone2, S K Hall3.   

Abstract

OBJECTIVE: In dried blood spot analysis, punch location and variations in applied sample volume and haematocrit can produce different measured concentrations of analytes. We investigated the magnitude of these effects in newborn screening in the UK.
METHODS: Heparinized blood spiked with thyroid stimulating hormone (TSH), phenylalanine, tyrosine, leucine, methionine, octanoyl carnitine (C8), and immunoreactive trypsinogen (IRT) was spotted onto filter paper: (i) at a constant haematocrit of 50% at various volumes, and (ii) at a range of haematocrits using a constant volume. Subpunches (3.2 mm) of the dried blood spots were then analysed.
RESULTS: Compared with a central punch from a 50 µL blood spot with 50% haematocrit, 10 µL spots can have significantly lower measured concentrations of all analytes, with decreases of 15% or more observed for leucine, methionine, phenylalanine, and tyrosine. Punching at the edge of a spot can increase measured concentrations up to 35%. Higher haematocrit decreased measured TSH and C8 yet increased amino acids and IRT by 15% compared with 50% haematocrit. Lower haematocrits had the opposite effect, but only with higher concentrations of some analytes.
CONCLUSIONS: Differences in blood spot size, haematocrit and punch location substantially affect measured concentrations for analytes used in the UK newborn screening programme, and this could affect false positive and negative rates. To minimize analytical bias, these variables should be controlled or adjusted for where possible.
© The Author(s) 2015.

Entities:  

Keywords:  Newborn screening; blood spot quality; dried blood spot; filter paper; haematocrit; punch location

Mesh:

Substances:

Year:  2015        PMID: 26113437     DOI: 10.1177/0969141315593571

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  15 in total

1.  What Is the Best Blood Sampling Time for Metabolic Control of Phenylalanine and Tyrosine Concentrations in Tyrosinemia Type 1 Patients?

Authors:  Esther van Dam; Anne Daly; Gineke Venema-Liefaard; Margreet van Rijn; Terry G J Derks; Patrick J McKiernan; M Rebecca Heiner-Fokkema; Anita MacDonald; Francjan J van Spronsen
Journal:  JIMD Rep       Date:  2017-01-25

2.  Whole exome and whole genome sequencing with dried blood spot DNA without whole genome amplification.

Authors:  Laia Bassaganyas; George Freedman; Dedeepya Vaka; Eunice Wan; Richard Lao; Flavia Chen; Mark Kvale; Robert J Currier; Jennifer M Puck; Pui-Yan Kwok
Journal:  Hum Mutat       Date:  2017-11-06       Impact factor: 4.878

Review 3.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

4.  MicroRNA in dried blood spots from patients with Aagenaes syndrome and evaluation of pre-analytical and analytical factors.

Authors:  Monica Atneosen-Åsegg; Maria Melheim; Runar Almaas
Journal:  Pediatr Res       Date:  2020-09-15       Impact factor: 3.756

Review 5.  Phenylketonuria.

Authors:  Francjan J van Spronsen; Nenad Blau; Cary Harding; Alberto Burlina; Nicola Longo; Annet M Bosch
Journal:  Nat Rev Dis Primers       Date:  2021-05-20       Impact factor: 52.329

6.  Response to Gelb et al.: "Comparison of tandem mass spectrometry to fluorimetry for newborn screening of LSDs".

Authors:  David S Millington
Journal:  Mol Genet Metab Rep       Date:  2017-07-06

Review 7.  Dried Blood Spots for Global Health Diagnostics and Surveillance: Opportunities and Challenges.

Authors:  Mark D Lim
Journal:  Am J Trop Med Hyg       Date:  2018-06-28       Impact factor: 2.345

Review 8.  Performance of laboratory tests used to measure blood phenylalanine for the monitoring of patients with phenylketonuria.

Authors:  Stuart J Moat; Danja Schulenburg-Brand; Hugh Lemonde; James R Bonham; Cas W Weykamp; Joanne V Mei; Graham S Shortland; Rachel S Carling
Journal:  J Inherit Metab Dis       Date:  2019-10-02       Impact factor: 4.750

9.  Reference values of amino acids, acylcarnitines and succinylacetone by tandem mass spectrometry for use in newborn screening in southwest Colombia.

Authors:  Nora Céspedes; Angela Valencia; Carlos Alberto Echeverry; Maria Isabel Arce-Plata; Cristóbal Colón; Daisy E Castiñeiras; Paula Margarita Hurtado; Jose Angel Cocho; Sócrates Herrera; Myriam Arévalo-Herrera
Journal:  Colomb Med (Cali)       Date:  2017-09-30

10.  A Detailed Analysis of the Factors Influencing Neonatal TSH: Results From a 6-Year Congenital Hypothyroidism Screening Program.

Authors:  Giulia Di Dalmazi; Maria Assunta Carlucci; Daniela Semeraro; Cesidio Giuliani; Giorgio Napolitano; Patrizio Caturegli; Ines Bucci
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-17       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.